Commercial Services and Supplies
Company Overview of Womancare Global International
WomanCare Global International is a non-profit charitable organization that focuses on women’s reproductive health. The organization distributes reproductive healthcare products, establishes partnerships with healthcare and pharmaceutical companies, and monitors product manufacturing. It offers contraceptive, miscarriage and pregnancy, and feminine hygiene management products. WomanCare Global International is headquartered in London, United Kingdom with an additional office in San Diego, California.
7 Wootton Street
London, SE1 8TG
Key Executives for Womancare Global International
Chief Executive Officer and Member of Board of Directors
Chief Operating Officer and Chief Financial Officer
Compensation as of Fiscal Year 2016.
Womancare Global International Key Developments
WomanCare Global Launches Improved Woman's Condom in Zambia
Mar 22 16
WomanCare Global announced it has launched the Maximum Diva Woman's Condom in Zambia with partner, Population Services International (PSI), as part of the United States Agency for International Development (USAID) and Swedish Agency for International Development (SIDA) co-funded project, Expanding Effective Contraceptive Options (EECO). The goal of EECO is to support the introduction of new woman-initiated technologies and approaches to meet the needs of women and girls throughout their reproductive health life cycle. The Woman's Condom is a new type of female condom designed by global health organization, PATH, with the goal of increasing female condom use. The condom is made of polyurethane and unique design features include a small rounded cap to ease insertion and four small surgical foam dots that hold the condom in place instead of the inner ring found in other female condoms.
Woman Care Global to Market Dilapan-S(R) Hygroscopic Cervical Dilator with MEDICEM
Jul 27 15
Woman Care Global (WCG) has announced that it will market the Dilapan-S® Hygroscopic Cervical Dilator through an agreement with Czech Republic-based manufacturer MEDICEM in selected countries worldwide. Hygroscopic cervical dilators are used globally for cervical preparation in a broad spectrum of gynecological indications. The drug-free nature of Dilapan-S, made of patented AQUACRYL® hydrogel, makes it an ideal resource for physicians seeking cervical preparation without the added side effects caused by pharmaceutical based options. Dilapan-S is FDA cleared and CE-marked facilitating broad distribution worldwide. WCG will leverage their distribution network and regulatory expertise to facilitate product registration, market introduction and commercialization of Dilapan-S in the following first wave of countries: Brazil, Colombia, Finland, Kenya, Mexico, Nigeria, Russia and South Africa.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries